相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cassane-type diterpenes from Caesalpinia minax induce apoptosis in pituitary adenoma: structure-activity relationship, ER stress and Wnt/-catenin pathways
Zong-Yang Li et al.
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2017)
Furanodienone induces G0/G1 arrest and causes apoptosis via the ROS/MAPKs-mediated caspase-dependent pathway in human colorectal cancer cells: a study in vitro and in vivo
Ying Jiang et al.
CELL DEATH & DISEASE (2017)
A novel HDAC6 inhibitor Tubastatin A: Controls HDAC6-p97/VCP-mediated ubiquitination-autophagy turnover and reverses Temozolomide-induced ER stress-tolerance in GBM cells
Zong-yang Li et al.
CANCER LETTERS (2017)
The regulatory mechanisms of NG2/CSPG4 expression
Emmanuel Ampofo et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2017)
A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein
Manal Amoury et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Functional roles of CSPG4/NG2 in chondrosarcoma
Nuor S. M. Jamil et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2016)
The activation of NG2 expressing cells is downstream to microglial reaction and mediated by the transforming growth factor beta 1
Ping Xiang et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Theranostic Impact of NG2/CSPG4 Proteoglycan in Cancer
Pier Andrea Nicolosi et al.
THERANOSTICS (2015)
A CSPG4-specific immunotoxin kills rhabdomyosarcoma cells and binds to primary tumor tissues
Hannes Brehm et al.
CANCER LETTERS (2014)
Transcriptional and posttranslational regulation of insulin-like growth factor binding protein-3 by Akt3
Quanri Jin et al.
CARCINOGENESIS (2014)
Reduced promoter methylation and increased expression of CSPG4 negatively influences survival of HNSCC patients
Rolf Warta et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Insulin-like factor binding protein-3 promotes the G1 cell cycle arrest in several cancer cell lines
Chen Wu et al.
GENE (2013)
Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma
D. Kesanakurti et al.
ONCOGENE (2013)
Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival
Aurelie Poli et al.
ONCOTARGET (2013)
Triptolide inhibits proliferation and invasion of malignant glioma cells
Haipeng Zhang et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma
Agnete Svendsen et al.
ACTA NEUROPATHOLOGICA (2011)
NG2 expressed by macrophages and oligodendrocyte precursor cells is dispensable in experimental autoimmune encephalomyelitis
Martijn Moransard et al.
BRAIN (2011)
Furanodienone induces cell cycle arrest and apoptosis by suppressing EGFR/HER2 signaling in HER2-overexpressing human breast cancer cells
Ying-Wei Li et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial
Il Han Kim et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma
Matthew A. Price et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma
Jian Wang et al.
PLOS ONE (2011)
Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy
J. Dunn et al.
BRITISH JOURNAL OF CANCER (2009)
Maslinic acid, a natural triterpene from Olea europaea L., induces apoptosis in HT29 human colon-cancer cells via the mitochondrial apoptotic pathway
Fernando J. Reyes-Zurita et al.
CANCER LETTERS (2009)
Efficacy of temozolomide as adjuvant chemotherapy after postsurgical radiotherapy alone for glioblastomas
Deok-Joo Rhee et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2009)
Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease
Sherryline Jogie-Brahim et al.
ENDOCRINE REVIEWS (2009)
Postinjury Niches Induce Temporal Shifts in Progenitor Fates to Direct Lesion Repair after Spinal Cord Injury
Drew L. Sellers et al.
JOURNAL OF NEUROSCIENCE (2009)
Egr-1 regulates expression of the glial scar component phosphacan in astrocytes after experimental stroke
Heike Beck et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Differential phosphorylation of NG2 proteoglycan by ERK and PKCα helps balance cell proliferation and migration
Irwan T. Makagiansar et al.
JOURNAL OF CELL BIOLOGY (2007)
ICAM-1 expression determines malignant potential of cancer
Christina L. Roland et al.
SURGERY (2007)
Anti-inflammatory sesquiterpenes from Curcuma zedoaria
H Makabe et al.
NATURAL PRODUCT RESEARCH (2006)
Differential arterial/venous expression of NG2 proteoglycan in perivascular cells along microvessels: Identifying a venule-specific phenotype
WL Murfee et al.
MICROCIRCULATION (2005)
Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms
JB Yang et al.
JOURNAL OF CELL BIOLOGY (2004)
The NG2 proteoglycan: Past insights and future prospects
WB Stallcup
JOURNAL OF NEUROCYTOLOGY (2002)
AN2, the mouse homologue of NG2, is a surface antigen on glial precursor cells implicated in control of cell migration
J Stegmüller et al.
JOURNAL OF NEUROCYTOLOGY (2002)
Cytokines regulate expression of the type 1 interleukin-1 receptor in rat hippocampal neurons and glia
WJ Friedman
EXPERIMENTAL NEUROLOGY (2001)
EGR1 target genes in prostate carcinoma cells identified by microarray analysis
J Svaren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
